TrialEuropean urology oncology2023

Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial.

Javier C Angulo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.